Tang, D., Kroemer, G., & Kang, R. (2021). Oncogenic KRAS blockade therapy: Renewed enthusiasm and persistent challenges. Molecular Cancer, 20(1), 1. https://doi.org/10.1186/s12943-021-01422-7
Chicago Style (17th ed.) CitationTang, Daolin, Guido Kroemer, and Rui Kang. "Oncogenic KRAS Blockade Therapy: Renewed Enthusiasm and Persistent Challenges." Molecular Cancer 20, no. 1 (2021): 1. https://doi.org/10.1186/s12943-021-01422-7.
MLA (9th ed.) CitationTang, Daolin, et al. "Oncogenic KRAS Blockade Therapy: Renewed Enthusiasm and Persistent Challenges." Molecular Cancer, vol. 20, no. 1, 2021, p. 1, https://doi.org/10.1186/s12943-021-01422-7.
Warning: These citations may not always be 100% accurate.